Application of infrared-beam laser therapy in the postoperative period in patients with nodular toxic goiter
DOI:
https://doi.org/10.14739/2310-1210.2022.5.259568Keywords:
nodular toxic goiter, infrared laser, surgical, treatmentAbstract
The question of postoperative management for patients with nodular toxic goiter (NTG) using an infrared-wave laser remains poorly investigated and highly debatable, which creates conditions for further investigation of this issue.
Aim. To evaluate the results of infrared-beam laser therapy in patients with NTG in the early and long-term postoperative periods after organ-preserving surgical interventions and thyroidectomies.
Materials and methods. The main group of 35 (50.7 %) patients was examined after additional postoperative infrared-beam laser therapy (1–3 courses) while the comparison group of 34 (49.3 %) patients did not receive this treatment.
Results. Thyroidectomy prevailed in the structure of surgeries in the main group (20 (57.1 %) cases). Organ-sparing surgeries were performed in 15 (42.9 %) patients. In the comparison group, 18 (52.9 %) thyroidectomies and 16 (47.1 %) thyroid resections were performed.
Conclusions. Almost half of NTG cases (14 (41.2 %) in the main group and 15 (42.9 %) in the comparison group were unifocal mono- or lobar nodular affection which provided an opportunity to perform organ-sparing surgeries. No postoperative hypoparathyroidism was observed in the patients who underwent surgical resection. All the cases of this disorder were observed in patients after total thyroidectomy – 7 (35.0 %) in the main group and 8 (44.4 %) in the comparison group, P = 0.2956. The application of infrared-beam therapy to the postoperative area stimulated blood flow in the tissues and led to renewal of the parotid function: the parathormone level in the main group was restored in the average period of 3.5 (1.5; 6.0) months and in the comparison group – in 6.5 (3.5; 9.0) months, P = 0.0412. The postoperative use of infrared-beam laser therapy in patients with organ-sparing surgical interventions allowed reducing the dose of replacement therapy from 25.0 (25.0; 50.0) µg in the comparison group to 12.5 (12.5; 25.0) µg in the main group, P = 0.0341.
References
Gilbert, J. (2017). Thyrotoxicosis - investigation and management. Clinical Medicine, 17(3), 274-277. https://doi.org/10.7861/clinmedicine.17-3-274
Kurbaniyazov Z. B., Babajanov A. S., Zainiev A. F., Rakhmanov K. E., & Davlatov S. S. (2020). Factor Analysis of Relapse of Nodular Goiter. American Journal of Medicine and Medical Sciences, 10(1), 59-65. https://doi.org/10.5923/j.ajmms.20201001.13
Donangelo, I., & Suh, Y. S. (2017). Subclinical Hyperthyroidism: When to Consider Treatment - American Family Physician. American Family Physician, 95(11), 710-716. Retrieved from https://www.aafp.org/afp/2017/0601/p710.html
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015). The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. European Thyroid Journal, 4(3), 149-163. https://doi.org/10.1159/000438750
Barczyński M. (2020). Introduction to focused issue on novel technologies in endocrine surgery. Gland surgery, 9(Suppl 2), S65-S68. https://doi.org/10.21037/gs.2020.01.10
Reeve, J., & Boden, I. (2016). The physiotherapy management of patients undergoing abdominal surgery. New Zealand Journal of Physiotherapy, 44(1), 33-49. https://doi.org/10.15619/nzjp/44.1.05
Teixeira, M. L., Vasconcellos, L. S., Oliveira, T. G., Petroianu, A., & Alberti, L. R. (2015). Prevention of abdominal adhesions and healing skin after peritoniectomy using low level laser. Lasers in surgery and medicine, 47(10), 817-823. https://doi.org/10.1002/lsm.22423
Tamhane, S., & Gharib, H. (2016). Thyroid nodule update on diagnosis and management. Clinical diabetes and endocrinology, 2, 17. https://doi.org/10.1186/s40842-016-0035-7
LiVolsi, V., & Baloch, Z. (2018). The Pathology of Hyperthyroidism. Frontiers In Endocrinology, 9, 737. https://doi.org/10.3389/fendo.2018.00737
Durante, C., Costante, G., Lucisano, G., Bruno, R., Meringolo, D., Paciaroni, A., Puxeddu, E., Torlontano, M., Tumino, S., Attard, M., Lamartina, L., Nicolucci, A., & Filetti, S. (2015). The natural history of benign thyroid nodules. JAMA, 313(9), 926-935. https://doi.org/10.1001/jama.2015.0956
Shidlovskii, V. О., Deikalo, І. М., & Shidlovskyi, О. V. (2012). Khirurhiia zobu v endemichnomu rehioni [Surgery of goiter in endemic region]. Shpytalna khirurhiia, (2), 24-29. [in Ukrainian].
Cramon, P., Winther, K. H., Watt, T., Bonnema, S. J., Bjorner, J. B., Ekholm, O., Groenvold, M., Hegedüs, L., Feldt-Rasmussen, U., & Rasmussen, Å. K. (2016). Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study. Thyroid, 26(8), 1010-1018. https://doi.org/10.1089/thy.2016.0044
Höfling, D. B., Chavantes, M. C., Buchpiguel, C. A., Cerri, G. G., Marui, S., Carneiro, P. C., & Chammas, M. C. (2018). Safety and Efficacy of Low-Level Laser Therapy in Autoimmune Thyroiditis: Long-Term Follow-Up Study. International journal of endocrinology, 2018, 8387530. https://doi.org/10.1155/2018/8387530
Zavhorodnii, S. M., Gatia, М. S., Кubrak, М. А., & Danyliuk, М. B. (2021). Khirurhichne likuvannia khvorykh na vuzlovyi toksychnyi zob [Surgical treatment of patients with nodular toxic goiter]. Zaporozhye medical journal, 23(3), 370-374. [in Ukrainian]. https://doi.org/10.14739/2310-1210.2021.3.229724
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. 
